Diagnosis and management of hyponatremia in acute illness

Robert W. Schrier, Shweta Bansal

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

Purpose of review Hyponatremia is the most common electrolyte disorder present in hospitalized patients. Acute and severe hyponatremia can cause significant morbidity and mortality. The present review discusses the epidemiology, causes, and a practical approach to the diagnosis and management of acute and chronic hyponatremia, including the appropriate use of hypertonic saline and potential future use of the new V2 vasopressin receptor antagonists in critically ill patients. Recent findings The increasing knowledge of aquaporin water channels and the role of vasopressin in water homeostasis have enhanced our understanding of hyponatremic disorders. Increased vasopressin secretion due to nonosmotic stimuli leads to decreased electrolyte-free water excretion with resulting water retention and hyponatremia. Vasopressin receptor antagonists induce electrolyte-free water diuresis without natriuresis and kaliuresis. Phase three trials indicate that these agents predictably reduce urine osmolality, increase electrolyte-free water excretion, and raise serum sodium concentration. They are likely to become a mainstay of treatment of euvolemic and hypervolemic hyponatremia. Summary The correct diagnosis and management of hyponatremia is complex and requires a systematic approach. Vasopressin receptor antagonists are potential tools in the management of hyponatremia. Further studies are needed to determine their role in the treatment of acute, severe, life-threatening hyponatremia as well as chronic hyponatremia.

Original languageEnglish (US)
Pages (from-to)627-634
Number of pages8
JournalCurrent Opinion in Critical Care
Volume14
Issue number6
DOIs
StatePublished - Dec 2008
Externally publishedYes

Fingerprint

Hyponatremia
Electrolytes
Water
Aquaporins
Vasopressins
Natriuresis
Diuresis
Critical Illness
Osmolar Concentration
Epidemiology
Homeostasis
Sodium
Urine
Morbidity
Mortality
Therapeutics

Keywords

  • Aquaretics
  • Hyponatremia
  • Hypoosmolality
  • Vasopressin

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Diagnosis and management of hyponatremia in acute illness. / Schrier, Robert W.; Bansal, Shweta.

In: Current Opinion in Critical Care, Vol. 14, No. 6, 12.2008, p. 627-634.

Research output: Contribution to journalArticle

Schrier, Robert W. ; Bansal, Shweta. / Diagnosis and management of hyponatremia in acute illness. In: Current Opinion in Critical Care. 2008 ; Vol. 14, No. 6. pp. 627-634.
@article{02aa3f478232466684b3ae56c27b7b02,
title = "Diagnosis and management of hyponatremia in acute illness",
abstract = "Purpose of review Hyponatremia is the most common electrolyte disorder present in hospitalized patients. Acute and severe hyponatremia can cause significant morbidity and mortality. The present review discusses the epidemiology, causes, and a practical approach to the diagnosis and management of acute and chronic hyponatremia, including the appropriate use of hypertonic saline and potential future use of the new V2 vasopressin receptor antagonists in critically ill patients. Recent findings The increasing knowledge of aquaporin water channels and the role of vasopressin in water homeostasis have enhanced our understanding of hyponatremic disorders. Increased vasopressin secretion due to nonosmotic stimuli leads to decreased electrolyte-free water excretion with resulting water retention and hyponatremia. Vasopressin receptor antagonists induce electrolyte-free water diuresis without natriuresis and kaliuresis. Phase three trials indicate that these agents predictably reduce urine osmolality, increase electrolyte-free water excretion, and raise serum sodium concentration. They are likely to become a mainstay of treatment of euvolemic and hypervolemic hyponatremia. Summary The correct diagnosis and management of hyponatremia is complex and requires a systematic approach. Vasopressin receptor antagonists are potential tools in the management of hyponatremia. Further studies are needed to determine their role in the treatment of acute, severe, life-threatening hyponatremia as well as chronic hyponatremia.",
keywords = "Aquaretics, Hyponatremia, Hypoosmolality, Vasopressin",
author = "Schrier, {Robert W.} and Shweta Bansal",
year = "2008",
month = "12",
doi = "10.1097/MCC.0b013e32830e45e3",
language = "English (US)",
volume = "14",
pages = "627--634",
journal = "Current Opinion in Critical Care",
issn = "1070-5295",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Diagnosis and management of hyponatremia in acute illness

AU - Schrier, Robert W.

AU - Bansal, Shweta

PY - 2008/12

Y1 - 2008/12

N2 - Purpose of review Hyponatremia is the most common electrolyte disorder present in hospitalized patients. Acute and severe hyponatremia can cause significant morbidity and mortality. The present review discusses the epidemiology, causes, and a practical approach to the diagnosis and management of acute and chronic hyponatremia, including the appropriate use of hypertonic saline and potential future use of the new V2 vasopressin receptor antagonists in critically ill patients. Recent findings The increasing knowledge of aquaporin water channels and the role of vasopressin in water homeostasis have enhanced our understanding of hyponatremic disorders. Increased vasopressin secretion due to nonosmotic stimuli leads to decreased electrolyte-free water excretion with resulting water retention and hyponatremia. Vasopressin receptor antagonists induce electrolyte-free water diuresis without natriuresis and kaliuresis. Phase three trials indicate that these agents predictably reduce urine osmolality, increase electrolyte-free water excretion, and raise serum sodium concentration. They are likely to become a mainstay of treatment of euvolemic and hypervolemic hyponatremia. Summary The correct diagnosis and management of hyponatremia is complex and requires a systematic approach. Vasopressin receptor antagonists are potential tools in the management of hyponatremia. Further studies are needed to determine their role in the treatment of acute, severe, life-threatening hyponatremia as well as chronic hyponatremia.

AB - Purpose of review Hyponatremia is the most common electrolyte disorder present in hospitalized patients. Acute and severe hyponatremia can cause significant morbidity and mortality. The present review discusses the epidemiology, causes, and a practical approach to the diagnosis and management of acute and chronic hyponatremia, including the appropriate use of hypertonic saline and potential future use of the new V2 vasopressin receptor antagonists in critically ill patients. Recent findings The increasing knowledge of aquaporin water channels and the role of vasopressin in water homeostasis have enhanced our understanding of hyponatremic disorders. Increased vasopressin secretion due to nonosmotic stimuli leads to decreased electrolyte-free water excretion with resulting water retention and hyponatremia. Vasopressin receptor antagonists induce electrolyte-free water diuresis without natriuresis and kaliuresis. Phase three trials indicate that these agents predictably reduce urine osmolality, increase electrolyte-free water excretion, and raise serum sodium concentration. They are likely to become a mainstay of treatment of euvolemic and hypervolemic hyponatremia. Summary The correct diagnosis and management of hyponatremia is complex and requires a systematic approach. Vasopressin receptor antagonists are potential tools in the management of hyponatremia. Further studies are needed to determine their role in the treatment of acute, severe, life-threatening hyponatremia as well as chronic hyponatremia.

KW - Aquaretics

KW - Hyponatremia

KW - Hypoosmolality

KW - Vasopressin

UR - http://www.scopus.com/inward/record.url?scp=57149083284&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57149083284&partnerID=8YFLogxK

U2 - 10.1097/MCC.0b013e32830e45e3

DO - 10.1097/MCC.0b013e32830e45e3

M3 - Article

C2 - 19005303

AN - SCOPUS:57149083284

VL - 14

SP - 627

EP - 634

JO - Current Opinion in Critical Care

JF - Current Opinion in Critical Care

SN - 1070-5295

IS - 6

ER -